Skip to content
Stay updated with the latest tech trends, gadget reviews, a…

The Zimbabwean Government Turns Down ‘Unbalanced’ American Health Aid Deal Due to Data Concerns

Medical funding illustration
The offered American funding was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has rejected a significant American healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of the United States' request for sensitive data.

The decision was revealed after a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the deal was "skewed".

A government spokesman later explained that the United States was demanding access to health data for scientific study and commercial purposes while was not willing to guarantee the resulting advantages from future medical innovations.

"We are forced to start the challenging and unfortunate task of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has urged continued negotiations to find a agreement acceptable to both sides so the country's vital HIV treatment initiative can be sustained.

Wider Implications

This development comes after a similar case in Kenya, where a high court blocked a related health funding agreement following legal challenges were filed about the security of citizens' medical information.

Since resuming the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had administered aid for the US government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral agreements to boost openness and responsibility.

As per reports, 16 nations in Africa have so far signed similar health pacts, representing over $18.3bn in committed funds.

Details of the Rejected Deal

The money for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this cooperation could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment through American-funded programmes," Tremont commented.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any equivalent assurance of access to any medical innovations – like new medicines or tests – that might result from that provided information," his statement read.

"Put simply, our nation would provide the raw materials for medical research with no assurance that the resulting innovations would be accessible to our citizens if a new disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already set up through the global health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.

"This mechanism is intended to ensure that when a nation provides its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the capability to develop them."

The government's concerns over the US deal "are not meant as anti-American sentiment," he added.

"We are open to further discussions with our US partners on how subsequent co-operation could be structured in a manner that honours the independence and interests of each country."

Medical Community Reaction

Medical experts stated it acknowledged the government's concerns, but suggested that talks must proceed since a large portion of the country's HIV programmes were funded by international support.

"Where technical issues exist, including those involving information security or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group commented.

This impasse emphasises the complex tensions between accepting vital international aid and protecting a country's data in an increasingly data-driven world.

KB
About the author

Kelsey Bowman

A tech journalist with over a decade of experience covering UK innovations and digital trends.

MegaCoreDirect

Type to search articles.